Increase in Candida parapsilosis fungemia in critical care units: a 6-years study

scientific article published on 4 June 2010

Increase in Candida parapsilosis fungemia in critical care units: a 6-years study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S11046-010-9322-5
P698PubMed publication ID20524154

P2093author name stringAli Kaya
Feza Otag
Gülden Ersöz
Elif Sahin Horasan
Ahmet Oner Kurt
Musa Göksu
Sevim Karaçorlu
P2860cites workDelaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortalityQ24530412
Epidemiological trends in nosocomial candidemia in intensive careQ25255762
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance studyQ29616607
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY ParQ30453440
Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillanceQ30994297
Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003.Q34680777
Candida parapsilosis, an emerging fungal pathogenQ34852747
Global surveillance of in vitro activity of micafungin against Candida: a comparison with caspofungin by CLSI-recommended methods.Q35073614
Increasing incidence of Candida parapsilosis candidemia with caspofungin usageQ37032961
Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospitalQ37576521
Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibilityQ37613000
The epidemiology of candidemia in two United States cities: results of a population-based active surveillanceQ41696774
In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillanceQ42222929
High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: epidemiology and antifungal susceptibility.Q43250363
Epidemiology of candidemia in oncology patients: a 6-year survey in a Portuguese central hospitalQ43297951
Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infectionQ43438479
Attributable mortality of nosocomial candidemia, revisitedQ44386169
Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategiesQ44913001
High frequency of Candida parapsilosis on the hands of healthy hostsQ45202625
Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.Q50700185
Observational study on candidaemia at a university hospital in southern Italy from 1998 to 2004Q60639244
Outbreak of fungemia due to Candida parapsilosis in a pediatric oncology unitQ60639245
Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional StudyQ61833672
Rising Incidence of Candida parapsilosis Fungemia in Patients with Hematologic Malignancies: Clinical Aspects, Predisposing Factors, and Differential Pathogenicity of the Causative StrainsQ63762171
Nosocomial acquisition of Candida albicans: an epidemiologic studyQ70770545
Fungal sepsis: multisite colonization versus fungemiaQ72765075
The epidemiology of hematogenous candidiasis caused by different Candida speciesQ73441200
Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemiaQ79803990
Secular trends of candidemia in a large tertiary-care hospital from 1988 to 2000: emergence of Candida parapsilosisQ80374897
Candidemia in immunocompromised and immunocompetent critically ill patients: a prospective comparative studyQ80382945
Nosocomial bloodstream infections associated with Candida species in a Turkish University HospitalQ82504322
P433issue4
P921main subjectCandida parapsilosisQ144068
fungemiaQ3491700
P1104number of pages6
P304page(s)263-268
P577publication date2010-06-04
P1433published inMycopathologiaQ15763210
P1476titleIncrease in Candida parapsilosis fungemia in critical care units: a 6-years study
P478volume170

Reverse relations

cites work (P2860)
Q38511946Antifungal drug resistance among Candida species: mechanisms and clinical impact
Q43595310Aspartyl proteinase, phospholipase, esterase and hemolysin activities of clinical isolates of the Candida parapsilosis species complex
Q38233262Candidaemia observed at a university hospital in Milan (northern Italy) and review of published studies from 2010 to 2014.
Q42680559Candidemia in non-ICU surgical wards: Comparison with medical wards.
Q34528210Catheter-related Candida bloodstream infection in intensive care unit patients: a subgroup analysis of the China-SCAN study
Q46484431Characterization of the Candida parapsilosis complex in East China: species distribution differs among cities
Q41544911Distribution of yeast isolates from invasive infections and their in vitro susceptibility to antifungal agents: evidence from 299 cases in a 3-year (2010 to 2012) surveillance study
Q36898053Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project)
Q40276130Epidemiology, species distribution, clinical characteristics and mortality of candidaemia in a tertiary care university hospital in Turkey, 2007-2014.
Q39322474Fungemia caused by Candida species in a children's public hospital in the city of São Paulo, Brazil: study in the period 2007-2010.
Q60923177Increase in Candida parapsilosis candidemia in cancer patients
Q35363662Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France

Search more.